Shirley V. Wang

Brigham and Women's Hospital, Harvard Medical School, United States

Disclosure information not submitted.

Presentation(s):

• SC-22 - Advanced Methods: Let's Git it started: transparency and reproducibility across the RWE study lifecycle with HARPER, Git and GitHub Copilot

  Saturday, August 23, 2025
  2:30 PM - 6:00 PM ET

• SW-1A - Building transparency and reproducibility into the practice of pharmacoepidemiology and outcomes research

  Sunday, August 24, 2025
  1:30 PM - 3:00 PM ET

• 2F-04 - Tree-based Scan Statistics to Evaluate Drug Safety in Pediatric Populations: Sulfamethoxazole/trimethoprim as a Positive Test Case

  Sunday, August 24, 2025
  4:15 PM - 4:30 PM ET

• 3A-01 - Cardiovascular Effectiveness of Semaglutide: Using Real-World Data to Predict Findings of the Ongoing SOUL Cardiovascular Outcomes Trial

  Monday, August 25, 2025
  8:15 AM - 8:30 AM ET

• 3D-04 - Pruning to increase computational efficiency for tree-based scan statistics

  Monday, August 25, 2025
  9:00 AM - 9:15 AM ET

• 4F-02 - Screening for Pediatric Safety Alerts Following Antipsychotic Treatment Initiation using a Tree-Based Scan Statistics Approach

  Monday, August 25, 2025
  4:30 PM - 4:45 PM ET

• 6C-03 - Using Real-World Data to Predict Findings of an Ongoing Phase IV Trial: Glycemic Control of Semaglutide vs Standard of Care

  Tuesday, August 26, 2025
  2:00 PM - 2:15 PM ET